Tool might help predict adverse events in children with cancer
from Medscape Medical News
Cancer patients who develop chemotherapy-induced febrile neutropenia are at risk for invasive infections, so standard treatment is emergency hospitalization and intravenous antimicrobial therapy. But patients could be spared this treatment if it were possible to identify those who were at low risk. New risk-adapted treatment guidelines have been developed for adults, but so far no consensus has emerged on how to predict adverse-event risk in pediatric patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063